Novel Borazines: Syntheses and Elaboration
Novel Borazines: Syntheses and Elaboration
批准号:
9488516
负责人:
GARY A MOLANDER
金额:
$25.16万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-15 至 2019-05-31
关键词:
AgrochemicalsAlkenesAlkynesAminationAminesArchitectureAreaBenzeneBenzofuransBindingBiologicalBiological TestingCarbonCharacteristicsChemicalsChemistryCollectionCouplingDevelopmentDimensionsElectrostaticsFamilyGlareGoalsHandHistone DeacetylaseHybridsHydrogen BondingIndolesInvestigationIsoquinolinesIsoxazolesLibrariesMethodsModelingModernizationMolecularNaphthalenesNatureNitrogenPatternPharmaceutical PreparationsPharmacologic SubstancePharmacologyProcessPropertyProteinsProxyReactionReagentResearchResortRestRouteSiteStructureSystemTimeTransition ElementsWorkanalogbasebenzimidazolebenzothiophenecatalystdesigndrug candidatedrug discoveryfascinateflexibilityinventionmaterials sciencenovelnovel strategiesnovel therapeuticsprogramspublic health relevancepyridinequinoline
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The invention of novel reactive building blocks and their incorporation into unique substructural platforms present outstanding opportunities to explore and create new chemical space. The overarching goal of our research program is to facilitate the construction of organic molecules by developing such new reagents and subsequently exploiting the novel reactivity patterns for those reagents as a means to access new chemical architectures. Herein are described investigations that we propose will serve to open vast new possibilities for novel molecular designs incorporating borazine isosteres of a variety of important aromatic and heteroaromatic systems. Relatively simple aromatic/heteroaromatic compounds, and particularly biaryls, dominate libraries of compounds typically generated by pharmaceutical companies because they can preferentially bind to a number of proteins, thus making them ideal platforms for the design of potent and highly specific drugs. Although these structural motifs have served well in the discovery of a wide-range of pharmacologically active materials, there is a growing recognition that current "undruggable" targets may not be undruggable at all, but rather the recalcitrance observed may be reflective of the limited range of chemical space accessed in current collections. The proposed research seeks to open new chemical space within the aromatic/heteroaromatic domain. Nearly all of the borazine substructures proposed to be created are unique, and neither the reactivity nor the physicochemical properties of the compounds proposed have ever been studied in a systematic manner. Despite being known for more than five decades, the borazine class of heteroaromatics has rarely been studied in the context of drug discovery, presumably because of their relatively limited synthetic accessibility. It is this glaring deficiency of reliable, effcient, and flexible routes to diverse azaborines that the research proposed seeks to redress. The synthetic methods described, combined with "classical" approaches to a variety of borazines, will provide extraordinary access to novel chemical space. More importantly, the ability to manipulate these platforms further in unprecedented ways will allow these systems to be more fully decorated by facile methods, in many cases in a highly selective, sustainable manner without resorting to transition metal-catalyzed reactions or directing groups. The borazines thus represent a fascinating hybrid between aromatic and heteroaromatic reactivity patterns and those of classical organoborons and amines that has not been previously exploited, and we will take maximum advantage of this in the development of unprecedented transformations.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1021/acs.joc.6b02574
发表时间:
2017-01-06
期刊:
The Journal of organic chemistry
影响因子:
--
作者:
[Davies GH, Zhou ZZ, Jouffroy M, Molander GA]
通讯作者:
Molander GA
DOI:
10.1021/acs.joc.6b00435
发表时间:
2016-05-06
期刊:
The Journal of organic chemistry
影响因子:
--
作者:
[Davies GH, Molander GA]
通讯作者:
Molander GA
DOI:
10.1021/acs.joc.7b00747
发表时间:
2017-05-19
期刊:
The Journal of organic chemistry
影响因子:
--
作者:
[Davies GHM, Mukhtar A, Saeednia B, Sherafat F, Kelly CB, Molander GA]
通讯作者:
Molander GA
DOI:
10.1021/acs.joc.7b01331
发表时间:
2017-08-04
期刊:
The Journal of organic chemistry
影响因子:
--
作者:
[Davies GHM, Jouffroy M, Sherafat F, Saeednia B, Howshall C, Molander GA]
通讯作者:
Molander GA
Accessing New Chemical Space via Organic Synthesis
-
批准号:9977334
-
项目类别:
-
资助金额:$2.99万
-
财政年份:2019
-
负责人:GARY A MOLANDER
-
依托单位:
Accessing New Chemical Space via Organic Synthesis
-
批准号:10408077
-
项目类别:
-
资助金额:$56.0万
-
财政年份:2019
-
负责人:GARY A MOLANDER
-
依托单位:
Accessing New Chemical Space via Organic Synthesis
-
批准号:10170385
-
项目类别:
-
资助金额:$60.17万
-
财政年份:2019
-
负责人:GARY A MOLANDER
-
依托单位:
A Novel Mechanistic Paradigm for Cross-Coupling
-
批准号:8854288
-
项目类别:
-
资助金额:$35.14万
-
财政年份:2015
-
负责人:GARY A MOLANDER
-
依托单位:
A Novel Mechanistic Paradigm for Cross-Coupling
-
批准号:9052207
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2015
-
负责人:GARY A MOLANDER
-
依托单位:
Novel Boronic Acids for Pilot-Scale Screening
-
批准号:7684187
-
项目类别:
-
资助金额:$36.67万
-
财政年份:2008
-
负责人:GARY A MOLANDER
-
依托单位:
Novel Boronic Acids for Pilot-Scale Screening
-
批准号:7557527
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2008
-
负责人:GARY A MOLANDER
-
依托单位:
Novel Boronic Acids for Pilot-Scale Screening
-
批准号:7884270
-
项目类别:
-
资助金额:$36.39万
-
财政年份:2008
-
负责人:GARY A MOLANDER
-
依托单位:
Development of Heterosubstituted Organotrifluoroborates
-
批准号:7494153
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2007
-
负责人:GARY A MOLANDER
-
依托单位:
Novel Organoboron Chemistry Utilizing Tetrahydroxydiborane
-
批准号:8341469
-
项目类别:
-
资助金额:$37.66万
-
财政年份:2007
-
负责人:GARY A MOLANDER
-
依托单位:
Novel Organoboron Chemistry Utilizing Tetrahydroxydiborane
-
批准号:8849455
-
项目类别:
-
资助金额:$33.83万
-
财政年份:2007
-
负责人:GARY A MOLANDER
-
依托单位:
Novel Organoboron Chemistry Utilizing Tetrahydroxydiborane
-
批准号:8516052
-
项目类别:
-
资助金额:$32.65万
-
财政年份:2007
-
负责人:GARY A MOLANDER
-
依托单位:
Development of Heterosubstituted Organotrifluoroborates
-
批准号:7287941
-
项目类别:
-
资助金额:$29.59万
-
财政年份:2007
-
负责人:GARY A MOLANDER
-
依托单位:
Development of Heterosubstituted Organotrifluoroborates
-
批准号:7658902
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2007
-
负责人:GARY A MOLANDER
-
依托单位:
Development of Heterosubstituted Organotrifluoroborates
-
批准号:7902216
-
项目类别:
-
资助金额:$30.23万
-
财政年份:2007
-
负责人:GARY A MOLANDER
-
依托单位:
Agilent 5973 GC/MS System
-
批准号:6439157
-
项目类别:
-
资助金额:$10.55万
-
财政年份:2002
-
负责人:GARY A MOLANDER
-
依托单位:
CATALYTIC PROCESSES FOR SELECTIVE ORGANIC SYTHESIS
-
批准号:6556461
-
项目类别:
-
资助金额:$8.08万
-
财政年份:1993
-
负责人:GARY A MOLANDER
-
依托单位:
INTRAMOLECULAR REDUCTIVE COUPLING REACTIONS
-
批准号:6525759
-
项目类别:
-
资助金额:$23.78万
-
财政年份:1993
-
负责人:GARY A MOLANDER
-
依托单位:
CATALYTIC PROCESSES FOR SELECTIVE ORGANIC SYTHESIS
-
批准号:6125391
-
项目类别:
-
资助金额:$13.01万
-
财政年份:1993
-
负责人:GARY A MOLANDER
-
依托单位:
NEW CATALYTIC PROCESSES FOR SELECTIVE ORGANIC SYNTHESIS
-
批准号:3308051
-
项目类别:
-
资助金额:$14.19万
-
财政年份:1993
-
负责人:GARY A MOLANDER
-
依托单位:
海外基金